Journal Information
Vol. 19. Issue 2.
Pages 120-121 (February 2023)
Share
Download PDF
Vol. 19. Issue 2.
Pages 120-121 (February 2023)
Letter to the Editor
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment
Anakinra, una alternativa potencial en el tratamiento de la infección respiratoria grave por SARS-CoV-2 refractaria a tocilizumab: comentario
Visits
11
This item has received
Article information
These are the options to access the full texts of the publication Reumatología Clínica (English Edition)